• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Insufficient influenza vaccination coverage in giant cell arteritis. A French population-based study

tetano

Editor, Senior Moderator
Rev Med Interne. 2019 Dec 26. pii: S0248-8663(19)31185-3. doi: 10.1016/j.revmed.2019.12.009. [Epub ahead of print] [h=1][Insufficient influenza vaccination coverage in giant cell arteritis. A French population-based study].[/h]
[Article in French]

Pugnet G[SUP]1[/SUP], Mouni? M[SUP]2[/SUP], Lapeyre-Mestre M[SUP]3[/SUP], Moulis G[SUP]4[/SUP], Sailler L[SUP]5[/SUP].
[h=3]Author information[/h] 1 Universit? de Toulouse III, 31062 Toulouse, France; Inserm, UMR1027, 31000 Toulouse, France; Service de m?decine interne, CHU de Toulouse, 1, place Baylac, 31059 Toulouse cedex 09, France; Centre d'investigation clinique 1436, CHU de Toulouse, 31059 Toulouse, France. Electronic address: pugnet.g@chu-toulouse.fr. 2 Universit? de Toulouse III, 31062 Toulouse, France; Inserm, UMR1027, 31000 Toulouse, France. 3 Universit? de Toulouse III, 31062 Toulouse, France; Inserm, UMR1027, 31000 Toulouse, France; Centre d'investigation clinique 1436, CHU de Toulouse, 31059 Toulouse, France; Laboratoire de pharmacologie m?dicale et clinique, facult? de m?decine, universit? de Toulouse III, 31000 Toulouse, France; Service de pharmacologie clinique, CIC 1436, CHU de Toulouse, 31000 Toulouse, France. 4 Universit? de Toulouse III, 31062 Toulouse, France; Inserm, UMR1027, 31000 Toulouse, France; Service de m?decine interne, CHU de Toulouse, 1, place Baylac, 31059 Toulouse cedex 09, France; Centre d'investigation clinique 1436, CHU de Toulouse, 31059 Toulouse, France. 5 Universit? de Toulouse III, 31062 Toulouse, France; Inserm, UMR1027, 31000 Toulouse, France; Service de m?decine interne, CHU de Toulouse, 1, place Baylac, 31059 Toulouse cedex 09, France.

[h=3]Abstract[/h] [h=4]PURPOSE:[/h] To evaluate the rate of seasonal influenza vaccination coverage (IVC) in incident giant cell arteritis (GCA) patients compared with controls.
[h=4]METHODS:[/h] The vaccination rate was estimated from vaccine dispensation. IVC was compared between GCA and their controls using longitudinal multivariate Poisson regression.
[h=4]RESULTS:[/h] During the influenza campaigns from 2005-2006 to 2010-2011, the IVC rates in the GCA group and the control group ranged from 60.8 to 74.7% vs. 56.6 to 70.4%, respectively. Incident GCA influenza vaccination rate was 20% higher than controls (RR=1.20 ; IC 1.09 to 1.32, P<0.001).
[h=4]CONCLUSION:[/h] IVC in incident GCA was statistically better than controls.
Copyright ? 2019 Soci?t? Nationale Fran?aise de M?decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.


[h=4]KEYWORDS:[/h] Art?rite ? cellules g?antes; Giant cell arteritis; Grippe; Influenza; Vaccination

PMID: 31883837 DOI: 10.1016/j.revmed.2019.12.009
 
Back
Top Bottom